Fauci Attorney Rejects Senate Request for Second Appearance, Citing Fifth Amendment Assertions

Anthony Fauci will not appear again before the U.S. Senate in connection with the panel’s ongoing COVID-19 investigation, according to a report on a dispute over testimony requests. Fauci’s attorney declined to agree to a second Senate appearance after Sen. Ron Johnson sought additional questioning, the report said, arguing that the renewed appearance would amount to “political harassment.”

The reported refusal centers on Fauci’s prior use of the Fifth Amendment during the investigation. Fox News reported that Fauci has invoked the constitutional protection more than 100 times in prior COVID-19 questioning connected to the Senate inquiry. The attorney’s position, as described in the report, was that additional Senate proceedings would not change Fauci’s constitutional posture and should not be pursued through repeated demands for testimony.

Sen. Johnson’s request, according to the reporting, would have required Fauci to testify again before the Senate. The attorney’s response rejected that request, framing the effort as harassment rather than a legitimate pursuit of testimony. The dispute also reflects how Senate oversight can collide with constitutional protections when a witness believes compelled testimony could create self-incrimination risk.

The Fifth Amendment issue is central to the procedural conflict. In U.S. practice, a witness may assert the privilege against self-incrimination in response to specific questions rather than serving as a blanket refusal in all circumstances. The report’s claim that Fauci invoked the Fifth Amendment more than 100 times suggests the dispute has been ongoing throughout earlier phases of the Senate inquiry.

A key practical effect of the refusal is timing and access to live testimony. Senate committees often seek witness appearances to establish timelines, evaluate decision-making, and test documentary records under oath. If Fauci does not agree to a second appearance, the committee’s ability to directly probe the witness’s account may be limited to other witnesses, public records, or written materials, depending on what the committee has already obtained.

The episode also underscores how oversight disputes can become constitutional and political at the same time. While Congress has authority to investigate matters within its jurisdiction, the attorney’s stated rationale, as described by the report, is that repeated appearance demands cross into improper pressure. That framing, if contested, can lead to further committee actions, including possible contempt proceedings if a witness refuses to testify when ordered, though the report did not specify any next steps beyond the rejection of the request.

For now, the reported development leaves the Senate inquiry to proceed without Fauci’s second appearance, at least on the schedule sought by Sen. Johnson. Whether the committee will pursue other options or modify its approach is not detailed in the reporting described, but the constitutional dispute is likely to remain a focal point for how the Senate handles testimony requests tied to the COVID-19 investigation.

Separately, the dispute highlights a broader pattern in congressional oversight of contentious public-health and policy episodes from recent years, where witnesses and legal teams frequently contest the scope of questions and the legitimacy of repeated demands for testimony. In this case, the reported attorney response ties that broader theme to Fauci’s prior Fifth Amendment assertions and to the claim that the renewed appearance request is politically motivated.